Clinical Trial Update: A Study of Hospital-at-Home for People Receiving Tarlatamab [NA]

View source ↗

Summary

This clinical trial update notes that a hospital-at-home study is evaluating care for patients with small cell lung cancer who are receiving tarlatamab, sponsor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Tarlatamab

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Small-cell Lung Cancer, Small Cell Lung Carcinoma | NA | Status: RECRUITING